Use of interferon beta-1a

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC L03AB07
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector MSMED_INTERFERONBETA1A

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

List of similar endpoints to Use of interferon beta-1a based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:


Venn diagram with a set fully inside an highlighted set Narrower endpoints:


Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals - - -
Unadjusted prevalence (%) - - -
Mean age at first event (years) - - -


Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -


Index endpoint: MSMED_INTERFERONBETA1A – Use of interferon beta-1a
GWS hits:

Survival analyses between endpoints


before Use of interferon beta-1a
after Use of interferon beta-1a

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of interferon beta-1a